Three countries reported more polio cases this week, including Pakistan, with three more wild poliovirus type 1 (WPV1) cases. In other developments, the United Kingdom reported three wastewater detections of circulating vaccine-derived poliovirus type 2 (cVDPV2), as Germany reported six more wastewater detections in six cities.
In its latest weekly update, the Global Polio Eradication Initiative (GPEI) said Pakistan's latest three WPV1 patients had paralysis onsets in November and were from Khyber Pakhtunkhwa and Sindh provinces. Pakistan is one of two countries where WPV1 is still endemic and, like Afghanistan, has reported a sharp rise in cases this year. For 2024, the country has now reported 59 cases. A media report today from Pakistan said four additional cases have been reported, which would raise the country's total to 63.
Elsewhere, two African countries reported more cVDPV2 cases. Chad reported 2 illnesses with paralysis onsets in September and October, putting its total for the year at 22. Nigeria reported 5 more cases, all with October paralysis onsets, boosting its number for 2024 to 86.
Wastewater detections in Europe and Gaza
GPEI also reported advance notifications of wastewater detections in the United Kingdom and Finland. The detection in Finland was reported by the media earlier this week. The UK detections are from samples collected in November from London, Leeds, and East Worthing. Five European countries have recently detected cVDPV 2 in wastewater.
Germany, which reported its initial detections earlier this month, confirmed six more wastewater isolates collected in November from six different cities: Bonn, Dresden, Duesseldorf, Hamburg, Cologne, and Mainz. The GPEI said all are linked to a strain that originated in Nigeria's Zamfara state. The group added that all five European countries that have reported detections, which also includes Spain and Poland, have strong disease surveillance and high routine immunization levels.
In its report, the GPEI also reported six more positive environmental samples in Gaza, an area that reported a human case this summer, which prompted a vaccine drive in the area.